scispace - formally typeset
M

Michael Haber

Researcher at McGill University Health Centre

Publications -  12
Citations -  1425

Michael Haber is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Dendritic spine & Postsynaptic potential. The author has an hindex of 11, co-authored 12 publications receiving 1278 citations. Previous affiliations of Michael Haber include McGill University.

Papers
More filters
Journal ArticleDOI

Astrocytes Are Endogenous Regulators of Basal Transmission at Central Synapses

TL;DR: It is shown that astrocytes in the hippocampal CA1 region detect synaptic activity induced by single-synaptic stimulation and increase basal synaptic transmission, finding an essential role in the regulation of elementary synaptic communication and providing insight into fundamental aspects of brain function.
Journal ArticleDOI

Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses

TL;DR: This work presents a system that can be used to characterize the intricate relationship between astrocytic processes and synaptic structures in situ using organotypic hippocampal slices, a preparation that retains the three-dimensional architecture ofAstrocyte–synapse interactions.
Journal ArticleDOI

EphA4 signaling regulates phospholipase Cgamma1 activation, cofilin membrane association, and dendritic spine morphology.

TL;DR: It is demonstrated that ephrin stimulation of EphA4 leads to the recruitment and activation of phospholipase Cγ1 (PLCγ1) in heterologous cells and in hippocampal slices and modulate the association of the actin depolymerizing/severing factor cofilin with the plasma membrane.
Journal ArticleDOI

Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury

TL;DR: It is shown that recombinant secretory leukocyte protease inhibitor injected intraperitoneally localizes to the nucleus of circulating leukocytes, is detected in the injured spinal cord, reduces activation of nuclear factor-kappaB and expression of tumour necrosis factor-alpha, and might be useful for the treatment of acute spinal cord injury.